Piramal Pharma (PPLPHARMA.NSE) Q4 2024 Earnings

23OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.7
-0.22
0.25
0.73

Details

Expected EPS
N/A
Actual EPS
0.18561937990750002
Surprise EPS
0.19
Surprise Percent
+∞%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of 0.18561937990750002 per share for Q4 2024.

0 Comments

Share your thoughts